Lung Cancer News and Research

Latest Lung Cancer News and Research

SBRT improves survival in patients with inoperable non-small cell lung cancer

SBRT improves survival in patients with inoperable non-small cell lung cancer

SBRT may improve survival rates for lung-cancer patients: Study

SBRT may improve survival rates for lung-cancer patients: Study

Human Genome Sciences announces Phase 2 results of mapatumumab combination therapy for NSCLC

Human Genome Sciences announces Phase 2 results of mapatumumab combination therapy for NSCLC

Clarient's Ovotax test may help improve patients’ response to taxane therapy

Clarient's Ovotax test may help improve patients’ response to taxane therapy

AstraZeneca Canada's IRESSA receives approval for treatment of NSCLC

AstraZeneca Canada's IRESSA receives approval for treatment of NSCLC

Colon cancer patients often not treated with recommended level of chemotherapy

Colon cancer patients often not treated with recommended level of chemotherapy

Despite accomplishments and improvements, cancer remains too common disease in the U.S.

Despite accomplishments and improvements, cancer remains too common disease in the U.S.

Dual role of Notch signalling pathway

Dual role of Notch signalling pathway

Endobronchial ultrasound: More precise and less invasive than other lung cancer staging methods

Endobronchial ultrasound: More precise and less invasive than other lung cancer staging methods

Poniard Pharmaceuticals sells over 4.2M common shares to Commerce Court Small Cap Value Fund

Poniard Pharmaceuticals sells over 4.2M common shares to Commerce Court Small Cap Value Fund

CytRx plans five Phase 2 clinical trials with oncology drug candidates

CytRx plans five Phase 2 clinical trials with oncology drug candidates

Prioritizing end of life care for cancer patients

Prioritizing end of life care for cancer patients

Two Phase 3 studies of Sutent in advanced breast cancer fail to meet primary endpoints

Two Phase 3 studies of Sutent in advanced breast cancer fail to meet primary endpoints

Pfizer discontinues ADVIGO 1018 trial of figitumumab-erlotinib combination therapy for advanced NSCLC

Pfizer discontinues ADVIGO 1018 trial of figitumumab-erlotinib combination therapy for advanced NSCLC

OXiGENE signs definitive agreement to sell Common Stock

OXiGENE signs definitive agreement to sell Common Stock

Peregrine Pharmaceuticals' third-quarter fiscal 2010 total revenues up 45%

Peregrine Pharmaceuticals' third-quarter fiscal 2010 total revenues up 45%

ImmunoCellular Therapeutics' dendritic cell-based vaccination with CSCs demonstrates survival benefits

ImmunoCellular Therapeutics' dendritic cell-based vaccination with CSCs demonstrates survival benefits

Biomoda, Obio collaborate to expand Biomoda’s lung cancer screening program for veterans into Ohio

Biomoda, Obio collaborate to expand Biomoda’s lung cancer screening program for veterans into Ohio

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

Children's Hospital Boston develops new web site, releases video message on current state of stem cell research

Children's Hospital Boston develops new web site, releases video message on current state of stem cell research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.